Beijing Kawin Technology Share-holding Co Ltd
SSE:688687

Watchlist Manager
Beijing Kawin Technology Share-holding Co Ltd Logo
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Watchlist
Price: 23 CNY 0.48% Market Closed
Market Cap: 3.9B CNY
Have any thoughts about
Beijing Kawin Technology Share-holding Co Ltd?
Write Note

Beijing Kawin Technology Share-holding Co Ltd
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Beijing Kawin Technology Share-holding Co Ltd
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Other Current Liabilities
ÂĄ58m
CAGR 3-Years
1%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Other Current Liabilities
ÂĄ1.5B
CAGR 3-Years
-7%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Other Current Liabilities
ÂĄ1.8B
CAGR 3-Years
38%
CAGR 5-Years
74%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Other Current Liabilities
ÂĄ1.9B
CAGR 3-Years
53%
CAGR 5-Years
54%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Other Current Liabilities
ÂĄ2.5B
CAGR 3-Years
23%
CAGR 5-Years
55%
CAGR 10-Years
58%
Imeik Technology Development Co Ltd
SZSE:300896
Other Current Liabilities
ÂĄ121.8m
CAGR 3-Years
33%
CAGR 5-Years
72%
CAGR 10-Years
N/A
No Stocks Found

Beijing Kawin Technology Share-holding Co Ltd
Glance View

Market Cap
3.9B CNY
Industry
Biotechnology

Beijing Kawin Technology Share-Holding Co., Ltd. provides biotechnology treatment solutions and medicines. The company is headquartered in Beijing, Beijing and currently employs 647 full-time employees. The company went IPO on 2021-02-08. The firm's recombinant human interferon α2b and compound glycyrrhizin drugs are applied to treat viral diseases. The firm mainly distributes its products within domestic market.

Intrinsic Value
26.97 CNY
Undervaluation 15%
Intrinsic Value
Price

See Also

What is Beijing Kawin Technology Share-holding Co Ltd's Other Current Liabilities?
Other Current Liabilities
58m CNY

Based on the financial report for Dec 31, 2023, Beijing Kawin Technology Share-holding Co Ltd's Other Current Liabilities amounts to 58m CNY.

What is Beijing Kawin Technology Share-holding Co Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
18%

Over the last year, the Other Current Liabilities growth was 5%. The average annual Other Current Liabilities growth rates for Beijing Kawin Technology Share-holding Co Ltd have been 1% over the past three years , 18% over the past five years .

Back to Top